pharmaceutical investing OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
pharmaceutical investing OncoMed Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
pharmaceutical investing DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer
Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services
QIMC Highlights Technical Advisory Role on First Atlas Matane Natural Hydrogen Project Following Quebec Parliamentary Committee Appearance
